{{'Tue, 14 Mar 2023 08:30:00 -0400' | dateFormatUsFilter}}
Novo Nordisk to lower U.S. prices of several pre-filled insulin pens and vials up to 75% for people living with diabetes in January 2024
Read more
{{'Wed, 01 Feb 2023 05:15:00 -0500' | dateFormatUsFilter}}
Novo Nordisk's sales increased by 26% in Danish kroner and by 16% at constant exchange rates to USD 25.0 billion in 2022
Read more
{{'Thu, 12 Jan 2023 20:28:00 -0500' | dateFormatUsFilter}}
Novo Nordisk announces FDA approval of label update for Rybelsus® (semaglutide) allowing use as a first-line option for adults with type 2 diabetes
Read more
Here are our current job openings. If we don’t currently have an opening in your area of interest, we encourage you to create a job agent and candidate profile.